360 filings
Page 2 of 18
8-K
4g4pdjw8a49g1v
10 Aug 23
Tempest Reports Second Quarter 2023 Financial Results and Provides Business Update
4:27pm
8-K
8kewz3hkq9os
16 Jun 23
Departure of Directors or Certain Officers
4:22pm
8-K
vfufsu 36cwe9pkdwmw
10 May 23
Tempest Reports First Quarter 2023 Financial Results and Provides Business Update
4:21pm
ARS
5mv4537y1 uaw
1 May 23
Annual report to shareholders
4:15pm
DEFA14A
7maugwk
1 May 23
Additional proxy soliciting materials
4:11pm
8-K
n7d4l
28 Apr 23
Tempest Announces Positive Early Results from Global Randomized Phase 1b/2 Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma
8:30am
8-K
88blnn zdrham
31 Mar 23
Other Events
5:07pm
8-K
78htlhh823
22 Mar 23
Tempest Reports Year End 2022 Financial Results and Provides
5:27pm
8-K
j5nkik2u3s6mwlxbx0
29 Dec 22
Entry into a Material Definitive Agreement
4:06pm
8-K
9por5u2h4tdhkh7
8 Nov 22
Tempest Reports Third Quarter 2022 Financial Results and Provides Business Update
8:55am
8-K
c3quhh5l5 y8m9fw9g
23 Sep 22
Departure of Directors or Certain Officers
4:06pm
8-K
u3n9q8pbgqk98
15 Aug 22
Tempest Reports Second Quarter 2022 Financial Results and Provides Business Update
8:05am
S-8
9p9pr1 jmvbwb0az6n
21 Jun 22
Registration of securities for employees
8:05am
8-K
33nxk74
21 Jun 22
Departure of Directors or Certain Officers
7:31am